Scarica l'app Stockscreener
1.34
1.52%
0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PYXS Giù?
Forum
Previsione
Precedente Chiudi:
$1.32
Aprire:
$1.29
Volume 24 ore:
1.33M
Relative Volume:
2.78
Capitalizzazione di mercato:
$83.01M
Reddito:
-
Utile/perdita netta:
$-73.79M
Rapporto P/E:
-0.7283
EPS:
-1.84
Flusso di cassa netto:
$-77.44M
1 W Prestazione:
+8.94%
1M Prestazione:
+18.58%
6M Prestazione:
+4.69%
1 anno Prestazione:
-63.29%
Intervallo 1D:
$1.28
$1.43
Intervallo di 1 settimana:
$1.14
$1.43
Portata 52W:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Nome
Pyxis Oncology Inc
Settore
Industria
Telefono
(617) 221-9059
Indirizzo
321 HARRISON AVENUE, BOSTON
Confronta PYXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.34 | 76.90M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-08-08 | Iniziato | Stifel | Buy |
| 2024-05-07 | Ripresa | Jefferies | Buy |
| 2024-02-09 | Iniziato | BTIG Research | Buy |
| 2024-01-23 | Iniziato | Leerink Partners | Outperform |
| 2023-09-05 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-11-02 | Iniziato | BofA Securities | Neutral |
| 2021-11-02 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Jefferies | Buy |
Mostra tutto
Pyxis Oncology Inc Borsa (PYXS) Ultime notizie
Pyxis Oncology's Promising MICVO Developments and Merck Collaboration Earns Bullish Rating - AInvest
HC Wainwright Reaffirms 'Buy' Rating for Pyxis Oncology with $5 Target Price. - AInvest
Pyxis Oncology Inc. Breaks Below Key Support LevelJuly 2025 Breakouts & AI Driven Stock Reports - thegnnews.com
HC Wainwright Raises PT for Pyxis Oncology to $5 from $5 on Buy Rating - AInvest
Pyxis Oncology Q2 Earnings Miss Worsens Losses, Sparking Mixed Market Reactions - AInvest
Pyxis Oncology Q2 Earnings Disappoint; Mixed Backtest Signals Market Volatility - AInvest
Will Pyxis Oncology Inc. Recover After Recent DeclineWeekly Investment Summary & Entry Point Strategy Guides - beatles.ru
Is Pyxis Oncology Inc. trending in predictive chart modelsTrade Exit Report & Real-Time Volume Spike Alerts - Newser
Custom strategy builders for tracking Pyxis Oncology Inc.July 2025 Recap & Technical Buy Zone Confirmations - Newser
Is Pyxis Oncology Inc. stock risky to hold nowQuarterly Portfolio Report & Expert Curated Trade Ideas - thegnnews.com
Pyxis Oncology Insiders Recover Some Losses, Which Stand At US$65k - simplywall.st
Earnings visualization tools for Pyxis Oncology Inc.CPI Data & Reliable Breakout Forecasts - Newser
Pyxis Oncology Inc. stock prediction for this weekTrade Volume Summary & Detailed Earnings Play Strategies - Newser
How Pyxis Oncology Inc. stock performs during market volatilityJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser
Short interest data insights for Pyxis Oncology Inc.July 2025 Decliners & Fast Entry Momentum Alerts - Newser
Is now a turning point for Pyxis Oncology Inc.Treasury Yields & Real-Time Stock Entry Alerts - Newser
Pyxis Oncology Reports Q2 2025 EPS of ($0.30), Beating Estimates, with Revenue at $2.8 Million - AInvest
William Blair Analyst Reiterates Hold Rating on Pyxis Oncology - AInvest
Custom Dashboard Highlights Pyxis Oncology Inc. Price MomentumJuly 2025 Summary & Community Supported Trade Ideas - 선데이타임즈
How to integrate Pyxis Oncology Inc. into portfolio analysis toolsTrade Exit Summary & Detailed Earnings Play Alerts - Newser
Heatmap analysis for Pyxis Oncology Inc. and competitorsMarket Activity Summary & Daily Entry Point Trade Alerts - Newser
Buy Rating for Pyxis Oncology: Promising Prospects for Micvo and Strong Financial Position - TipRanks
Drawdown in Pyxis Oncology Inc. May Be Nearing End2025 Institutional Moves & High Return Trade Guides - kangso.co.kr
Pyxis Oncology Reports Q2 2025 Financial Results - TipRanks
Pyxis Oncology Reports Q2 2025 Financial Results, Cash Runway Extended to H2 2026. - AInvest
Pyxis Oncology: Navigating Cost Efficiency and Market Potential in the ADC Revolution - AInvest
Pyxis Oncology reports Q2 EPS (30c), consensus (35c) - TipRanks
Pyxis Oncology Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pyxis Oncology: A High-Potential Biotech Play with Near-Term Clinical Catalysts and Strengthening Financial Position - AInvest
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update - MarketScreener
What makes Pyxis Oncology Inc. stock price move sharply2025 Momentum Check & Long-Term Safe Investment Ideas - mustnews.co.kr
Can Pyxis Oncology Inc. Bounce Back From Weekly LowWall Street Watch & Short-Term Swing Trade Alerts - newsyoung.net
What does recent volatility data suggest for Pyxis Oncology Inc.Portfolio Performance Report & Consistent Return Investment Signals - Newser
Using data models to predict Pyxis Oncology Inc. stock movementMarket Sentiment Summary & Smart Investment Allocation Tips - Newser
Visual analytics tools that track Pyxis Oncology Inc. performanceQuarterly Profit Review & Consistent Return Strategy Ideas - Newser
Pyxis Oncology Inc. stock momentum explainedMarket Rally & Long-Term Growth Stock Strategies - Newser
Statistical indicators supporting Pyxis Oncology Inc.’s strength2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Heatmap analysis for Pyxis Oncology Inc. and competitors [July 2025 Drop Watch]Weekly Breakout Stock Alerts - Newser
Can Pyxis Oncology Inc. recover in the next quarterEarnings Growth Report & Pattern Based Trade Signal System - Newser
Earnings visualization tools for Pyxis Oncology Inc. [July 2025 Closing Moves]Short-Term Swing Trade Alerts - Newser
Pyxis Oncology (PYXS) Projected to Post Earnings on Wednesday - Defense World
Real time scanner hits for Pyxis Oncology Inc. explainedPredictable Income Summary for Long-Term Trades - Newser
Should you hold or exit Pyxis Oncology Inc. nowPattern Breakout Tracker with Screener Tools - Newser
Pyxis Oncology Inc. stock chart pattern explainedTrend Confirmation Scanner with Entry Focus - Newser
Pyxis Oncology PYXS 2025Q2 Earnings Preview Downside Concerns Amid Revenue Uncertainty - AInvest
Why Pyxis Oncology Inc. stock attracts strong analyst attentionFree Triple Digit Growth Focused Trade Plan - Newser
Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):